SAN DIEGO, CA – February 2, 2015 – Viking Therapeutics, Inc., a clinical-stage company focused on developing novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced that it has entered into a research collaboration agreement with the Academic Medical Center (AMC) of ...Read the rest